Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Szabo, Attila ^a,b   Kovacs, Attila ^a   Frecska, Ede ^a   Rajnavolgyi, Eva ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; 5 METHOXY N,N DIMETHYLTRYPTAMINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; N,N DIMETHYLTRYPTAMINE; POLYINOSINIC POLYCYTIDYLIC ACID; PSYCHEDELIC AGENT; SIGMA 1 OPIATE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; 2-(4-MORPHOLINO)ETHYL-1-PHENYLCYCLOHEXANE-1-CARBOXYLATE; MORPHOLINE DERIVATIVE; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INFLUENZA VIRUS; INNATE IMMUNITY; MONOCYTE DERIVED DENDRITIC CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MONOCYTE; MOUSE;

ADAPTIVE IMMUNITY; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HALLUCINOGENS; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; METHOXYDIMETHYLTRYPTAMINES; MICE; MONOCYTES; MORPHOLINES; N,N-DIMETHYLTRYPTAMINE; RECEPTORS, SIGMA;

EID: 84924711991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106533     Document Type: Article

References (48)

1. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517-532.
2. Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124: 195-206.
3. Su TP (1982) Evidence for sigma opioid receptor: binding of [3H] SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223: 284-290.
4. Su TP, London ED, Jaffe JH (1988) Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 240: 219-221.
5. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, et al. (1994) Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 268: 9-18.
6. Wolfe SA Jr, Kulsakdinun C, Battaglia G, Jaffe JH, De Souza EB (1988) Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. J Pharmacol Exp Ther 247: 1114-1119. (Pubitemid 19022124)
7. Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131: 596-610. (Pubitemid 350017760)
8. Mori T, Hayashi T, Hayashi E, Su TP (2013) Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS One 8: e76941.
9. Zhu LX, Sharma S, Gardner B, Escuadro B, Atianzar K, et al. (2003) IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol 170: 3585-3591. (Pubitemid 36359226)
10. Carayon P, Bouaboula M, Loubet JF, Bourrie B, Petitpretre G, et al. (1995) The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-gamma and GM-CSF mRNA expression. Int J Immunopharmacol 17: 753-761.
11. Bourrie B, Bouaboula M, Benoit JM, Derocq JM, Esclangon M, et al. (1995) Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand. Eur J Immunol 25: 2882-2887.
12. Frecska E, Szabo A, Winkelman MJ, Luna LE, McKenna DJ (2013) A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm 120: 1295-1303.
13. Su TP, Hayashi T, Vaupel DB (2009) When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal 2: pe12.
14. Shen HW, Jiang XL, Winter JC, Yu AM (2010) Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab 11: 659-666.
15. Wallach JV (2009) Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception. Med Hypotheses 72: 91-94.
16. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, et al. (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323: 934-937.
17. Dos Santos RG, Valle M, Bouso JC, Nomdedeu JF, Rodriguez-Espinosa J, et al. (2011) Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. J Clin Psychopharmacol 31: 717-726.
18. Szabo A, Rajnavolgyi E (2013) Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses. Am J Clin Exp Immunol 2: 195-207.
19. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449: 419-426. (Pubitemid 47509552)
20. Belz GT, Nutt SL (2012) Transcriptional programming of the dendritic cell network. Nat Rev Immunol 12: 101-113.
21. Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, et al. (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143: 416-429.
22. Wohleb ES, Powell ND, Godbout JP, Sheridan JF (2013) Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J Neurosci 33: 13820-13833.
23. Szabo A, Bene K, Gogolak P, Rethi B, Lanyi A, et al. (2012) RLR-mediated production of interferon-beta by a human dendritic cell subset and its role in virus-specific immunity. J Leukoc Biol 92: 159-169.
24. Ruscher K, Inacio AR, Valind K, Rowshan Ravan A, Kuric E, et al. (2012) Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3- phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke. PLoS One 7: e45118.
25. Peviani M, Salvaneschi E, Bontempi L, Petese A, Manzo A, et al. (2014) Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol Dis 62: 218-232.
26. Fenizia C, Fiocchi M, Jones K, Parks RW, Ceribelli M, et al. (2014) Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells. J Virol 88: 393-402.
27. Strassman RJ, Qualls CR (1994) Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 51: 85-97. (Pubitemid 24054310)
28. Shen HW, Jiang XL, Yu AM (2011) Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice. Drug Metab Dispos 39: 1227-1234.
29. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
30. Pierson E, Simmons SB, Castelli L, Goverman JM (2012) Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev 248: 205-215.
31. Ousman SS, Tomooka BH, van Noort JM, Wawrousek EF, O'Connor KC, et al. (2007) Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 448: 474-479. (Pubitemid 47123511)
32. Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, et al. (2009) Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A 106: 14063-14068.
33. Jurgens HA, Amancherla K, Johnson RW (2012) Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci 32: 3958-3968.
34. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123-140. (Pubitemid 39490066)
35. Karkkainen J, Forsstrom T, Tornaeus J, Wahala K, Kiuru P, et al. (2005) Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scand J Clin Lab Invest 65: 189-199. (Pubitemid 40695210)
36. Axelrod J (1961) Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science 134: 343.
37. Christian ST, Harrison R, Quayle E, Pagel J, Monti J (1977) The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochem Med 18: 164-183. (Pubitemid 8213838)
38. Theodorou V, Chovet M, Eutamene H, Fargeau H, Dassaud M, et al. (2002) Antidiarrhoeal properties of a novel sigma ligand (JO 2871) on toxigenic diarrhoea in mice: mechanisms of action. Gut 51: 522-528.
39. Szabo A, Rajnavolgyi E (2013) The Brain-Immune-Gut Triangle: Innate Immunity in Psychiatric and Neurological Disorders. Current Immunology Review 9: 241-248.
40. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
41. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
42. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, et al. (2006) The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26: 4752-4762. (Pubitemid 44315314)
43. Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, et al. (2008) Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33: 441-456. (Pubitemid 350243354)
44. Krebs-Thomson K, Ruiz EM, Masten V, Buell M, Geyer MA (2006) The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology (Berl) 189: 319-329. (Pubitemid 44772815)
45. Jacob MS, Presti DE (2005) Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. Med Hypotheses 64: 930-937. (Pubitemid 40385946)
46. Katoh N, Soga F, Nara T, Tamagawa-Mineoka R, Nin M, et al. (2006) Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin Exp Immunol 146: 354-361. (Pubitemid 44581352)
47. O'Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, et al. (2006) A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107: 1010-1017. (Pubitemid 43156299)
48. Mothersill C, Saroya R, Smith RW, Singh H, Seymour CB (2010) Serum serotonin levels determine the magnitude and type of bystander effects in medium transfer experiments. Radiat Res 174: 119-123.